To read this content please select one of the options below:

Direct‐to‐consumer‐advertising of prescription medicines: A theoretical approach to understanding

Michael Harker (Faculty of Business, University of the Sunshine Coast, Maroochydore South, Australia)
Debra Harker (Faculty of Business, University of the Sunshine Coast, Maroochydore South, Australia)

Leadership in Health Services

ISSN: 1751-1879

Article publication date: 8 May 2007

1712

Abstract

Purpose

The pharmaceutical industry is a leader in research and development investment. New treatments need to be communicated to the market, and consumers are increasingly interested in learning about new drugs. Direct to consumer advertising of prescription medicines (DTCA) is a controversial practice where many of the arguments for and against are not supported by strong evidence. This paper aims to contribute to a research agenda that is forming in this area.

Design/methodology/approach

The paper reports on a systematic review that was conducted and applies accepted theoretical models to the DTCA context. The systematic review methodology is widely accepted in the medical sector and is successfully applied here in the marketing field.

Findings

The hierarchy of effects model is specifically applied to DTCA with a clear emphasis on consumer rights, empowerment, protection and knowledge.

Originality/value

This paper provides healthcare practitioners with insight into how consumers process DTCA messages and provides guidance into how to assist in this message processing.

Keywords

Citation

Harker, M. and Harker, D. (2007), "Direct‐to‐consumer‐advertising of prescription medicines: A theoretical approach to understanding", Leadership in Health Services, Vol. 20 No. 2, pp. 76-84. https://doi.org/10.1108/17511870710745411

Publisher

:

Emerald Group Publishing Limited

Copyright © 2007, Emerald Group Publishing Limited

Related articles